ArticleDiabetes care2022

Changes in Glucose Metabolism and Glycemic Status With Once-Weekly Subcutaneous Semaglutide 2.4 mg Among Participants With Prediabetes in the STEP Program.

Leigh Perreault et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.